VEGFA and wet macular degeneration: Before brolucizumab was introduced, several anti-VEGF have been approved to treat wet AMD which are pegaptanib (2004), ranibizumab (2006) and aflibercept (2011).[39,40] Pegaptanib is rarely used now due to the superiority of the other factors.